Hydralazine
Hydralazine is a second-line antihypertensive used for acute management of severe hypertension in preeclampsia, especially when labetalol or nifedipine are not suitable or effective. It is administered intravenously and acts as a direct vasodilator, lowering blood pressure quickly. However, it can cause more maternal side effects like tachycardia and headaches compared to other agents, which limits its use as a first-line option.
Treatment Type: Prescription Medication
Treatment Class: N/A
Treatment Modality: N/A
Review Summary
Based on the provided review, Hydralazine appears to be an effective second-line treatment for managing severe hypertension in preeclampsia, particularly when used after beta-blockers like labetalol. The review suggests it helps control blood pressure while minimizing the risk of reflex tachycardia, with a rating of 4 out of 5 from a medical professional.
This summary was generated by users' reviews
Breakdown by Category
Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.
Explore various treatment options to empower yourself in making a well-informed choice.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
5.0
AI Summary of User Experiences
Not medical advice.
Based on the provided review, Hydralazine appears to be an effective second-line treatment for managing severe hypertension in preeclampsia, particularly when used after beta-blockers like labetalol. The review suggests it helps control blood pressure while minimizing the risk of reflex tachycardia, with a rating of 4 out of 5 from a medical professional.
Reviews
Filter by reviewer type Pro